UrgentRx provides over-the-counter medications in an innovative, fast-acting powder format available in convenient, single-dose, credit card-sized packets for easier portability and accessibility. Initially developed for heart attack victims, who are 23% more likely to survive by taking aspirin at the first sign of a heart attack, UrgentRx's products also provide quick and easy relief from headaches, aches and pains, heartburn and upset stomach.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/21/12 | $3,000,000 | Series B |
JUMP Investors | undisclosed |
| 04/02/13 | $2,500,000 | Series B |
Boulevard Capital Partners David Bonderman Herb Simon Hilary Swank JUMP Investors Sam Zell | undisclosed |
